Predicting distant recurrence of ER+HER2-breast cancer after 5 years of endocrine therapy: The CTS5-tool validation in real life
View/ Open
Volume
80
DOI
10.1158/1538-7445.SABCS19-P5-06-08
Issue
ISSN
0008-5472
Metadata
Show full item recordAuthors
Van Cauwenberge, J; Sestak, I; Punie, K; Wildiers, H; Floris, G; Vergote, I; Berteloot, P; Van Gorp, T; Smeets, A; Van Nieuwenhuysen, ECollections
- Centre for Cancer Prevention [1181]